Expected hemoglobin decrease following percutaneous transluminal coronary angioplasty

American Journal of Cardiology

Volumn 80, Issue 1, 1997, Pages 71-74

  Jauch, Werner ^b   Kurnik, Peter B ^b   Hanlon, Sharon J ^b   Siegel, Jamie E ^b   Matthai Jr , William H ^a  

^a Department of Anesthesiology   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; HEPARIN;

ADULT; ANTICOAGULATION; ARTICLE; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROGNOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR ACCESS;

EID: 0031195211     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)90146-6     Document Type: Article

References (11)

1. 1. Lim R, Dyke L, Thomas J, Dymond DS. Novel approach to the interpretation of long-term "deterioration" in ejection fraction in individual patients with coronary artery disease. Br Heart J 1993;70:226-232.
2. 2. Altman DG. Practical Statistics for Medical Research. 1st ed. London: Chapman & Hall, 1991:307-315.
3. 3. Dupuis J, Lalonde G, Lemieux R, Rouleau JL. Tolerance to intravenous nitroglycerine in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetlycysteine. J Am Coll Cardiol 1990;16:923-932.
4. 4. Lis Y, Bennett D, Lambert G, Robson D. A preliminary double-blind study of intravenous nitroglycerin in acute myocardial infarction. Intensive Care Med 1984;10:179-184.
5. 5. Ishikawa K, Kanamaru S, Yotsukura M, Tsuya T, Shirato C, Yanagisawa A. Influence of peripheral intravenous contrast injection on the QRS complex in healthy men. Cardiovasc Res 1986;20;61-66.
6. 6. Morissette M, Gagnon RM, Lamoureux J, Lemire J. Effects of angiographic contrast media on colloid oncotic pressure. Am Heart J 1980;100:319-322.
7. 7. Haught WH, Sokol M, Kerensky RA, Mehta JL. Decrease in hematocrit after coronary stent placement and dextran therapy. Am J Cardiol 1995;76:314-315.
8. 8. Roccario ES, Schweiger MJ, Whitfield SS, Stikley W, Weil T, Urbano A, Porway M. Hematocrit fluctuations after percutaneous transluminal coronary angioplasty. Am J Cardiol 1991;68:977-978.
9. 9. Phillips SJ, Spector M, Zeff RH, Skinner JR, Toon RS, Grignon A, Kongtahworn C. Hematocrit changes after uncomplicated percutaneous coronary angioplasty. Am J Cardiol 1989;64:940.
10. 10. Fail PS, Maniet AR, Banka VS. Subcutaneous heparin in postangioplasty management: comparative trial with intravenous heparin. Am Heart J 1993;126:1059-1067.
11. 11. Adelman AG, Cohen EA, Kimball BP, Bonan R, Ricci DR, Webb JG, Laramee L, Barbeau G, Traboulsi M, Corbett BN, Schwartz L, Logan AG. A comparison of directional athrectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med 1993;329:228-233.